Integrated Biopharma INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
OQX
The reporting group, including the estate of Carl DeSantis, has ceased beneficial ownership of Integrated BioPharma, Inc. shares.
OQX
Damon DeSantis and CDDS 2.0, LLC have reported a combined 41.3% beneficial ownership stake in Integrated Biopharma, Inc. following a series of internal share transfers.